Fulgent Genetics, Inc.
FLGT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $695 | $613 | $521 | $566 |
| - Cash | $118 | $88 | $67 | $55 |
| + Debt | $0 | $7 | $8 | $8 |
| Enterprise Value | $578 | $532 | $462 | $519 |
| Revenue | $84 | $82 | $73 | $76 |
| % Growth | 2.8% | 11.4% | -3.6% | – |
| Gross Profit | $36 | $34 | $28 | $32 |
| % Margin | 42.2% | 42.1% | 38.6% | 41.8% |
| EBITDA | -$0 | -$15 | -$6 | -$10 |
| % Margin | -0.1% | -18.9% | -7.9% | -13% |
| Net Income | -$7 | -$19 | -$12 | -$6 |
| % Margin | -7.9% | -23.2% | -15.7% | -7.7% |
| EPS Diluted | -0.21 | -0.61 | -0.37 | -0.19 |
| % Growth | 65.6% | -64.9% | -94.7% | – |
| Operating Cash Flow | $11 | -$30 | -$4 | $25 |
| Capital Expenditures | -$6 | -$7 | -$5 | -$4 |
| Free Cash Flow | $5 | -$37 | -$9 | $21 |